An interventional study of Digital wellbeing promoting intervention with the BitHabit app in General Mental Health and Well-Being, Mental Disorders and Common Mental Disorders (CMD), sponsored by University of Eastern Finland. Active, not recruiting at 1 site in Finland. Open to participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by University of Eastern Finland · Not applicable, Interventional, and Prevention
Mental wellbeing is a major public health concern, and digital interventions have emerged as a scalable approach for promoting mental well-being and healthy lifestyle behaviors. However, evidence regarding long-term effectiveness and the role of user engagement remains limited. This study evaluates the effectiveness of the BitHabit digital wellbeing application in promoting mental wellbeing and healthy lifestyle among adults living in North Savo, Finland.
The BitHabit application is a digital behavior change intervention designed to support mental wellbeing through the adoption of small, self-selected wellbeing-promoting habits. The application incorporates principles of self-determination theory, habit formation, self-monitoring, and behavior change techniques. Participants select habits from a library of well-being-promoting activities and track their implementation over time.
The intervention study uses a stepped-wedge randomized controlled design in which all participants eventually receive access to the intervention, while participants awaiting access serve as controls. Adults aged 18 to 64 years living in North Savo were recruited between 2024 and 2025 through population registry sampling and open public recruitment. Following informed consent and baseline assessment, participants were randomly allocated to receive access to the intervention at different time points during the study.
Power calculations using Monte Carlo simulations indicated that approximately 1,600 participants would provide 80% power to detect a standardized mean difference of 0.30 in mental wellbeing (SWEMWBS), assuming four intervention sequences, five measurement occasions, a within-person intraclass correlation coefficient of 0.70, and 30% attrition.
The primary outcome mental wellbeing is assessed using the Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS). Secondary outcomes include depressive symptoms measured with the Patient Health Questionnaire (PHQ-9), self-reported capabilities, loneliness measured with the UCLA 3-item Loneliness Scale (UCLA-3), life satisfaction measured on a 0-10 scale, and self-reported health behaviours. Outcomes are measured at baseline and repeated follow-up assessments throughout the study. App usage data are used to evaluate intervention adoption and engagement and to examine whether effectiveness differs according to actual intervention use.
Statistical analyses will be conducted using mixed-effects regression models that account for the stepped-wedge design and repeated measurements within participants. Models will include fixed effects for intervention exposure and time, and a random intercept for participants. Estimates will be reported with 95% confidence intervals and a two-sided significance level of 0.05.
In addition to quantitative outcome assessments, participant experiences and acceptability of the intervention will be evaluated with user satisfaction questionnaires and qualitative interviews conducted among a subset of participants. These data will be used to assess perceived usefulness, user experiences, and opportunities for further development of the intervention.
In addition to questionnaire and app usage data, participants will be linked to regional and national administrative registers. Register-based follow-up covers the period from one year before study enrolment until up to ten years after study completion. Data sources include health and social care registers, prescription and reimbursement registers, employment-related registers, and population registers. These data will be used to evaluate the long-term effectiveness and cost-effectiveness of the intervention, including health service use, medication use, social outcomes, and associated costs.
2,148 studies on the registry are indexed under Mental Disorders; 425 are open to participants now.
This study's enrollment of 1,700 is above the median of 96 across 1,607 interventional studies indexed under Mental Disorders.
Browse Mental Disorders studies →University of Eastern Finland is the lead sponsor of 53 studies on the registry; 9 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Digital wellbeing promoting intervention with the BitHabit app
Behavioral: Digital wellbeing promoting intervention with the BitHabit app
Control group
The BitHabit intervention is a digital wellbeing application designed to support mental wellbeing through the adoption of small, self-selected wellbeing-promoting habits. Participants choose habits from a library covering areas such as physical activity, sleep, stress management, social relationships, recovery, and healthy daily routines. The intervention is based on self-determination theory, habit formation principles, and evidence-based behavior change techniques. Users can monitor their habit performance, receive reminders and notifications, and gradually integrate wellbeing-promoting behaviors into everyday life. Access to the intervention is provided through a web-based application and participants may continue using the application throughout the intervention period.
Short Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS)
A self-reported validated measure of health and wellbeing measured with the Warwick-Edinburgh Mental Wellbeing Scale (Sarasjärvi et al 2025; Tennant et al 2007). Scores range from 7 to 35 and higher scores indicate higher positive mental wellbeing.
Time frame: At baseline, 3 months, 6 months, 9 months, 12 months and 24 months.
Self-reported capabilities
Validated self-report measure based on the Capability Approach (Mäki-Opas et al 2022). It assesses individuals' perceived opportunities and freedoms to achieve valued ways of living across multiple life domains, including health, social relationships, participation, security, and personal development. Single items are coded from 1 to 7, higher indicating better perceived capabilities.
Time frame: At baseline, 3 months, 6 months, 9 months, 12 months and 24 months.
Life satisfaction
A single-item measure asking participants to rate their overall satisfaction with life on a scale from 0 to 10, where 0 indicates "completely dissatisfied" and 10 indicates "completely satisfied." Higher scores reflect greater subjective well-being and overall life satisfaction.
Time frame: At baseline, 3 months, 6 months, 9 months, 12 months and 24 months.
Plan to share: No — We do not have permission to share IPD from the participants.
Started May 2024 (actual). Primary completion is estimated for Dec 2026, 31 months after the start.
Of 841 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's planned 31 months is close to that.
Counting every sponsor, half of 856 studies reached it within 29 months; a quarter within 13 and three quarters within 45.
Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Eastern Finland